Persistence of Ebola virus in various body fluids during convalescence: Evidence and implications for disease transmission and control

Epidemiology and Infection

Volumn 144, Issue 8, 2016, Pages 1652-1660

  Chughtai, A A ^a   Barnes, M ^a   Macintyre, C R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Body fluids; Ebola virus; transmission

Indexed keywords

AQUEOUS HUMOR; BLOOD; BODY FLUID; BREAST MILK; CONDOM; CONJUNCTIVA; CONVALESCENCE; EBOLA HEMORRHAGIC FEVER; HUMAN; INFECTION CONTROL; PRACTICE GUIDELINE; REVIEW; SPERM; SYSTEMATIC REVIEW; URINE; VAGINAL SECRETION; VIRAL CLEARANCE; VIRUS TRANSMISSION; EBOLAVIRUS; ISOLATION AND PURIFICATION; TIME FACTOR; VIROLOGY;

VIRUS RNA;

BODY FLUIDS; CONVALESCENCE; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; RNA, VIRAL; TIME FACTORS;

EID: 84955570063     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268816000054     Document Type: Review

References (46)

1. World Health Organisation (WHO). Global alert and response (GAR). Ebola situation reports (http://www. who.int/csr/disease/ebola/situation-reports/en/). Accessed 5 October 2015
2. Francesconi P, et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerging Infectious Diseases 2003; 9: 1430-1437
3. MacIntyre CR, et al. Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations? International Journal of Nursing Studies 2014; 51: 1421-1426
4. Rodriguez LL, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S170-176
5. Kreuels B, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. New England Journal of Medicine 2014; 371: 2394-2401
6. Emond RT, et al. A case of Ebola virus infection. British Medical Journal 1977; 2: 541-544
7. Rowe AK, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S28-35
8. Bausch DG, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. Journal of Infectious Diseases 2007; 196 (Suppl. 2): S142-147
9. MacIntyre CR, Chughtai AA. Recurrence and reinfection with Ebola-A new paradigm. International Journal of Infectious Diseases (in press
10. Richards GA, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Critical Care Medicine 2000; 28: 240-244
11. Lyon GM, et al. Clinical care of two patients with Ebola virus disease in the United States. New England Journal of Medicine 2014; 371: 2402-2409
12. Ribner BS. Treating patients with Ebola virus infection in the U.S. Lessons learned at Emory University Hospital 2014 (https://www.uhc.edu/docs/5555-22-15801-EbolaLessonsLearned-presentationFINAL.pdf). Accessed 29 January 2015
13. Moreau M, et al. Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Eurosurveillance 2015; 20
14. Baggi FM, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Eurosurveillance 2014; 19
15. Christie A, et al. Possible sexual transmission of Ebola virus-Liberia, 2015. Morbidity and Mortality Weekly Report 2015; 64: 479-481
16. Toweh A, Farge E. Liberia confirms new Ebola case as outbreak spreads (http://www.reuters.com/article/2015/07/14/us-health-ebola-idUSKCN0PO1EN20150714). Accessed 30 July 2015
17. Varkey JB, et al. Persistence of Ebola virus in ocular fluid during convalescence. New England Journal of Medicine 2015; 372: 2423-2427
18. Varkey JB, et al. Persistence of Ebola virus in ocular fluid during convalescence. New England Journal of Medicine 2015; 372: 2469
19. Deen GF, et al. Ebola RNA persistence in semen of Ebola virus disease survivors-preliminary report. New England Journal of Medicine. Published online: 14 October 2015. doi: 10.1056/NEJMoa1511410
20. Formenty P, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clinical Infectious Diseases 2006; 42: 1521-1526
21. MacIntyre CR, et al. Uncertainty, risk analysis and change for Ebola personal protective equipment guidelines. International Journal of Nursing Studies 2014; 5: 899-903
22. Towner JS, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. Journal of Virology 2004; 78: 4330-4341
23. Johnson E, et al. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. International Journal of Experimental Pathology 1995; 76: 227-236
24. Farmer P. Re-infection after being PCR'd negative? 2014 (http://www.ebolainfo.org/reinfection-After-beingpcrd-negative-topic31097.html). Accessed 27 January 2015
25. Kelly JD, Richardson ET, Barry M. Persistent Ebola virus in the eye. New England Journal of Medicine 2015; 373: 1981-1982
26. Yeh S, Varkey JB, Crozier I. Persistent Ebola virus in the eye. New England Journal of Medicine 2015; 373: 1982-1983
27. Martini GA, Schmidt HA. Spermatogenic transmission of the 'Marburg virus'. Causes of Marburg simian disease [in German]. Klinische Wochenschrift 1968; 46: 398-400
28. Smith DH, et al. Marburg-virus disease in Kenya. Lancet 1982; 1: 816-820
29. Gear JS, et al. Outbreake of Marburg virus disease in Johannesburg. British Medical Journal 1975; 4: 489-93
30. Leroy EM, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355: 2210-2215
31. Heffernan RT, et al. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooue-Ivindo region, Northeastern Gabon, 1997. Journal of Infectious Diseases 2005; 191: 964-968
32. Deng IM, et al. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bulletin of theWorld Health Organization 1978; 56: 247-270
33. Gholipour B. U.S. Ebola survivors are likely now immune to virus strain, experts say 2014 (http://www. huffingtonpost.com/2014/08/25/ebola-survivors-immune-n-5711581.html). Accessed 27 January 2015
34. Baschiera D. Ebola outbreak: Darwin volunteer writes from Sierra Leone treatment centre, 'I just cry in my goggles' 2014 (http://www.abc.net.au/news/2014-11-26/darwin-ebola-volunteer-dan-baschiera-writes-from-sierraleone/5919516). Accessed 27 January 2015
35. Qiu X, et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Scientific Reports 2013; 3: 3365
36. Roels TH, et al. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S92-97
37. Ksiazek TG, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S177-187
38. Fitzpatrick G, et al. The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Medecins Sans Frontieres Ebola case management centre, Kailahun, Sierra Leone, June-October 2014. Journal of Infectious Diseases 2015; 212: 1-7
39. Mackay IM, Arden KE. Ebola virus in the semen of convalescent men. Lancet Infectious Diseases 2014; 15: 149-150
40. World Health Organization (WHO). Ebola virus disease http://www.who.int/mediacentre/factsheets/fs103/en/. Accessed 29 January 2015
41. World Health Organization (WHO). Frequently asked questions on Ebola virus disease (http://www.who.int/csr/disease/ebola/faq-ebola/en/). Accessed 2 January 2016
42. Toweh A. Liberia urges sexual caution to beat Ebola outbreak. Reuters (http://www.reuters.com/article/2015/03/29/us-health-ebola-liberia-idUSKBN0MP0QM20150329). Accessed 1 April 2015
43. Glaser E. Challenges in getting to zero, will abstinence be key? (http://www.ghdonline.org/ebola/discussion/challenges-in-getting-To-zero-will-Abstinence-be-k/?id=17796018&format=html&type=instant). Accessed 1 April 2015
44. Center for Disease Control and Prevention (CDC). Recommendations for breastfeeding/infant feeding in the context of Ebola (http://www.cdc.gov/vhf/ebola/hcp/recommendations-breastfeeding-infant-feeding-ebola.html). Accessed 10 February 2015
45. Boyle D. Ebola nurse Pauline Cafferkey now critically ill 2015 (http://www.telegraph.co.uk/news/health/news/11931143/Ebola-nurse-Pauline-Cafferkey-is-now-criticallyill. html). Accessed 18 October 2015
46. Franz DR, et al. Clinical recognition and management of patients exposed to biological warfare agents. Journal of the American Medical Association 1997; 278: 399-411